MYRON J. TONG, M.D., Ph.D.; SHIH-CHIEN SUN, M.D.; BERTON T. SCHAEFFER, M.D.; NAI-KWEI CHANG, M.D.; KWANG-JUEI LO, M.D.; ROBERT L. PETERS, M.D.
Serums from 55 patients with primary hepatocellular carcinoma were examined for the presence of hepatitis-associated antigen (HAA). Forty-four (80%) had the antigen in their serums; alpha fetoglobulins were detected in 32 of 55 serums analyzed (58%). One hundred and thirty-eight of 943 (14.6%) healthy Chinese control subjects with normal serum glutamic-pyruvic transaminase activity had HAA in their serums. There was no apparent correlation between the presence of alpha fetoglobulins and HAA positivity in patients with hepatocellular carcinoma.
TONG MJ, SUN S, SCHAEFFER BT, CHANG N, LO K, PETERS RL. Hepatitis-Associated Antigen and Hepatocellular Carcinoma in Taiwan. Ann Intern Med. ;75:687–691. doi: 10.7326/0003-4819-75-5-687
Download citation file:
Published: Ann Intern Med. 1971;75(5):687-691.
Gastroenterology/Hepatology, Gastrointestinal Cancer, Hematology/Oncology, Liver Cancer, Liver Disease.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use